← Browse by Condition
Medical Condition
renal cell carcinoma
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 2, Phase 3, Phase 1
ClinicalMetric tracks all active clinical trials for renal cell carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — renal cell carcinoma Clinical Trials
How many clinical trials are currently recruiting for renal cell carcinoma?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for renal cell carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for renal cell carcinoma?
renal cell carcinoma research spans Phase 1 (2 trials), Phase 2 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a renal cell carcinoma clinical trial?
Eligibility criteria for renal cell carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 2
Phase 3 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06699602 Phase 2
Recruiting
Enrollment
10 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT03288532 Phase 3
Recruiting
Enrollment
1,750 pts
Location
United Kingdom
Sponsor
University College, London
NCT04974671 Phase 2
Recruiting
Enrollment
30 pts
Location
United States
Sponsor
Yale University
NCT07300241 Phase 1
Recruiting
Enrollment
30 pts
Location
United States
Sponsor
Neomorph, Inc
NCT04510129
Recruiting
Enrollment
1,650 pts
Location
United States
Sponsor
Cofactor Genomics, Inc.
NCT06076538
Recruiting
Enrollment
97 pts
Location
United States
Sponsor
University of Texas Southweste...
NCT05059444
Recruiting
Enrollment
2,020 pts
Location
United States, Franc...
Sponsor
Guardant Health, Inc.
NCT06910657 Phase 1
Recruiting
Enrollment
78 pts
Location
United States, Austr...
Sponsor
ViroMissile, Inc.
NCT04623502
Recruiting
Enrollment
600 pts
Location
United States
Sponsor
University of Texas Southweste...
Related Conditions
urothelial carcinoma (2) hepatocellular carcinoma (2) colorectal cancer (2) metastatic renal cell carcinoma (1) oligoprogressive (1) progression (1) clear cell renal cell carcinoma (1) rcc (1) clear cell renal cell carcinoma metastatic (1) ccrcc (1) vhl associated clear cell renal cell carcinoma (1) vhl associated renal cell carcinoma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology